Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires (PH-HIBA)

The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.

Study Overview

• Status: Recruiting
• Conditions: Hypertension, Pulmonary Arterial

Detailed Description

The Institutional Registry of Pulmonary Hypertension includes patients prospectively with incident pulmonary hypertension type I. It also includes prevalent cases from our HMO who had diagnosis prior the beginning of the registry.

• Study Type: Observational
• Enrollment (Estimated): 200

Contacts and Locations

• Study Contact: Name: Ignacio M Bluro, MD; Phone Number: 5303 +541149590200; Email: ignacio.bluro@hospitalitaliano.org.ar

Study Locations

• Argentina
  • Buenos Aires, Argentina, 1181
    • Recruiting
    • Hospital Italiano de Buenos Aires
    • Contact: Ignacio M Bluro, MD; Phone Number: 5303 +541149590200; Email: ignacio.bluro@hiba.org.ar
    • Principal Investigator: Ignacio M Bluro, MD

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 17 years and older (Child, Adult, Older Adult)
• Accepts Healthy Volunteers: No

• Sampling Method: Non-Probability Sample

Study Population

Patients who meet inclusion criteria and none of exclusion criteria during the study period are eligible to this study. In the population, the PAH cohort will consist of those incident cases and prevalent cases PAH WHO group 1 aged ≥18 years between January 2017 and December 2030 who attended at Hospital Italiano of Buenos Aires.

Description

• Inclusion Criteria:

  1. Diagnosed with PAH WHO group 1 (2022 ESC/ESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) >15 mmHg and pulmonary vascular resistance (PVR) >2 WU, according to the 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
  2. Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires
  3. Aged ≥18 years at the index date.
• Exclusion Criteria History of lung transplantation surgery previously the baseline period

Study Plan

How is the study designed?

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Pulmonary Hypertension prevalence	Pulmonary Hypertension prevalence in our community.	1 year
Pulmonary Hypertension incidence	Pulmonary Hypertension incidence in our community	1 year

Secondary Outcome Measures

Outcome Measure	Time Frame
Mortality rate	1 year

Collaborators and Investigators

• Sponsor: Hospital Italiano de Buenos Aires
• Investigators: Principal Investigator: Ignacio M Bluro, MD, Hospital Italiano de Buenos Aires

Study record dates

Study Major Dates

• Study Start (Actual): January 1, 2017
• Primary Completion (Estimated): December 31, 2030
• Study Completion (Estimated): June 1, 2031

Study Registration Dates

• First Submitted: June 16, 2011
• First Submitted That Met QC Criteria: December 26, 2011
• First Posted (Estimated): December 29, 2011

Study Record Updates

• Last Update Posted (Actual): August 24, 2025
• Last Update Submitted That Met QC Criteria: August 19, 2025
• Last Verified: August 1, 2025

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Vascular Diseases; Cardiovascular Diseases; Respiratory Tract Diseases; Lung Diseases; Pulmonary Arterial Hypertension; Hypertension; Hypertension, Pulmonary
• Other Study ID Numbers: 1487

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No